LIVZON PHARMAC Valuation
| LP6 Stock | EUR 3.16 0.06 1.94% |
At this time, the firm appears to be overvalued. LIVZON PHARMAC GRP secures a last-minute Real Value of €2.7 per share. The latest price of the firm is €3.16. Our model forecasts the value of LIVZON PHARMAC GRP from inspecting the firm fundamentals such as Profit Margin of 0.15 %, return on equity of 0.13, and Return On Asset of 0.0514 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that LIVZON PHARMAC's price fluctuation is relatively risky at this time. Calculation of the real value of LIVZON PHARMAC GRP is based on 3 months time horizon. Increasing LIVZON PHARMAC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the LIVZON stock is determined by what a typical buyer is willing to pay for full or partial control of LIVZON PHARMAC GRP. Since LIVZON PHARMAC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LIVZON Stock. However, LIVZON PHARMAC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.16 | Real 2.7 | Hype 3.16 | Naive 2.92 |
The real value of LIVZON Stock, also known as its intrinsic value, is the underlying worth of LIVZON PHARMAC GRP Company, which is reflected in its stock price. It is based on LIVZON PHARMAC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of LIVZON PHARMAC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of LIVZON PHARMAC GRP helps investors to forecast how LIVZON stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LIVZON PHARMAC more accurately as focusing exclusively on LIVZON PHARMAC's fundamentals will not take into account other important factors: LIVZON PHARMAC Total Value Analysis
LIVZON PHARMAC GRP is now estimated to have takeover price of 0 with market capitalization of 3.86 B, debt of 22.97 M, and cash on hands of 1.14 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the LIVZON PHARMAC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 3.86 B | 22.97 M | 1.14 B |
LIVZON PHARMAC Investor Information
About 53.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 30th of May 2022. LIVZON PHARMAC GRP had 13:10 split on the 3rd of July 2019. Based on the measurements of operating efficiency obtained from LIVZON PHARMAC's historical financial statements, LIVZON PHARMAC GRP is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.LIVZON PHARMAC Asset Utilization
One of the ways to look at asset utilization of LIVZON is to check how much profit was generated for every dollar of assets it reports. LIVZON PHARMAC GRP makes use of its assets almost 0.0514 %, realizing 0.0514 cents for each euro of assets held by the firm. A growing asset utilization conveys that the company is being more competent with each euro of assets it secures. Strictly speaking, asset utilization of LIVZON PHARMAC shows how competent it operates for each euro spent on its assets.LIVZON PHARMAC Ownership Allocation
LIVZON PHARMAC GRP maintains a total of 309.83 Million outstanding shares. LIVZON PHARMAC GRP holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.LIVZON PHARMAC Profitability Analysis
The company reported the revenue of 12.18 B. Net Income was 684.16 M with profit before overhead, payroll, taxes, and interest of 7.75 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates LIVZON PHARMAC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in LIVZON PHARMAC and how it compares across the competition.
About LIVZON PHARMAC Valuation
The stock valuation mechanism determines LIVZON PHARMAC's current worth on a weekly basis. Our valuation model uses a comparative analysis of LIVZON PHARMAC. We calculate exposure to LIVZON PHARMAC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LIVZON PHARMAC's related companies.Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people.
8 Steps to conduct LIVZON PHARMAC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates LIVZON PHARMAC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct LIVZON PHARMAC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain LIVZON PHARMAC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine LIVZON PHARMAC's revenue streams: Identify LIVZON PHARMAC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research LIVZON PHARMAC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish LIVZON PHARMAC's growth potential: Evaluate LIVZON PHARMAC's management, business model, and growth potential.
- Determine LIVZON PHARMAC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate LIVZON PHARMAC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for LIVZON Stock analysis
When running LIVZON PHARMAC's price analysis, check to measure LIVZON PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIVZON PHARMAC is operating at the current time. Most of LIVZON PHARMAC's value examination focuses on studying past and present price action to predict the probability of LIVZON PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIVZON PHARMAC's price. Additionally, you may evaluate how the addition of LIVZON PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |